LGVN Longeveron LLC

USD 1.67 -0.05 -2.906977
Icon

Longeveron LLC (LGVN) Stock Analysis and Price Targets

COMMON STOCK | Biotechnology | NSD
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

Strong Buy

Top Analyst
Rating
stockTargetAdvisor

Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 1.67

-0.05 (-2.91)%

USD 9.21M

0.32M

USD 6.00(+259.28%)

N/A

Icon

LGVN

Longeveron LLC (USD)
COMMON STOCK | NSD
USD 1.67
0.00 0
Take a Tour
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

Strong Buy

Top Analyst
Rating
stockTargetAdvisor

Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 9.21M

N/A

USD 1.67

Longeveron LLC (LGVN) Stock Forecast

Show ratings and price targets of :
USD 6.00
(+259.28%)

Based on the Longeveron LLC stock forecast from 1 analysts, the average analyst target price for Longeveron LLC is USD 6.00 over the next 12 months. Longeveron LLC’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Longeveron LLC is Bearish, which is based on 1 positive signals and 7 negative signals. At the last closing, Longeveron LLC’s stock price was USD 1.67. Longeveron LLC’s stock price has changed by -16.92% over the past week, +314.91% over the past month and -94.01% over the last year.

No recent analyst target price found for Longeveron LLC
No recent average analyst rating found for Longeveron LLC

Company Overview Longeveron LLC

Longeveron Inc., a clinical stage biotechnology company, develops cellular therapies for aging-related and life-threatening conditions in the United States and Japan. The company's lead investigational product is the LOMECEL-B, an allogeneic mesenchymal stem cell formulation sour...Read More

https://longeveron.com

Life Science and Technology Park, Miami, FL, United States, 33136

23

December

USD

USA

Adjusted Closing Price for Longeveron LLC (LGVN)

Loading...

Unadjusted Closing Price for Longeveron LLC (LGVN)

Loading...

Share Trading Volume for Longeveron LLC Shares

Loading...

Compare Performance of Longeveron LLC Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for LGVN

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To Longeveron LLC (Sector: Biotechnology )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
VRTX
Vertex Pharmaceuticals Inc -3.06 (-0.76%) USD107.38B 29.93 21.06

ETFs Containing LGVN

Symbol Name LGVN's Weight Expense Ratio Price(Change) Market Cap
no data

Frequently Asked Questions About Longeveron LLC (LGVN) Stock

Based on ratings from 1 analysts Longeveron LLC's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Bearish. The stock has 1 buy, sell and hold ratings.

Unfortunately we do not have enough data on LGVN's stock to indicate if its a good dividend stock.

Based on targets from 1 analysts, the average taret price for LGVN is USD 6.00 over the next 12 months. The maximum analyst target price is USD 6 while the minimum anlayst target price is USD 6.

Unfortunately we do not have enough data on LGVN's stock to indicate if its overvalued.

The last closing price of LGVN's stock was USD 1.67.

The most recent market capitalization for LGVN is USD 9.21M.

Based on targets from 1 analysts, the average taret price for LGVN is projected at USD 6.00 over the next 12 months. This means that LGVN's stock price may go up by +259.28% over the next 12 months.

We can't find any ETFs which contains Longeveron LLC's stock.

As per our most recent records Longeveron LLC has 23 Employees.

Longeveron LLC's registered address is Life Science and Technology Park, Miami, FL, United States, 33136. You can get more information about it from Longeveron LLC's website at https://longeveron.com.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...